1. Home
  2. PEBO vs ANAB Comparison

PEBO vs ANAB Comparison

Compare PEBO & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

HOLD

Current Price

$38.31

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$48.68

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBO
ANAB
Founded
1902
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
PEBO
ANAB
Price
$38.31
$48.68
Analyst Decision
Hold
Strong Buy
Analyst Count
7
8
Target Price
$42.50
★ $87.25
AVG Volume (30 Days)
427.5K
★ 510.1K
Earning Date
10-20-2026
11-03-2026
Dividend Yield
★ 4.40%
N/A
EPS Growth
N/A
★ 91.02
EPS
★ 1.59
N/A
Revenue
$197,000.00
★ $234,603,000.00
Revenue This Year
$7.39
$17.97
Revenue Next Year
$56.09
$36.88
P/E Ratio
$23.99
★ N/A
Revenue Growth
N/A
★ 157.01
52 Week Low
$28.01
$30.27
52 Week High
$42.29
$73.30

Technical Indicators

Market Signals
Indicator
PEBO
ANAB
Relative Strength Index (RSI) 55.70 48.05
Support Level $37.53 $44.43
Resistance Level $39.33 $51.27
Average True Range (ATR) 0.71 2.29
MACD 0.30 0.44
Stochastic Oscillator 93.79 58.84

Price Performance

Historical Comparison
PEBO
ANAB

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: